Ignite Creation Date:
2025-12-25 @ 2:52 AM
Ignite Modification Date:
2025-12-31 @ 11:35 PM
Study NCT ID:
NCT06999733
Status:
RECRUITING
Last Update Posted:
2025-05-31
First Post:
2025-05-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Assessing KB801 for the Treatment of Stage 2 or 3 Neurotrophic Keratitis
Sponsor:
Krystal Biotech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-14
First Submit QC Date:
None
Study First Post Date:
2025-05-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-23
Last Update Post Date:
2025-05-31
Last Update Post Date Type:
ACTUAL